Fortress Biotech (NASDAQ: FBIO) — Perfil da empresa, notícias e dados financeiros

Fortress Biotech (NASDAQ:FBIO) is a biopharmaceutical company dedicated to acquiring, developing, and commercializing high-potential marketed and development-stage drugs and drug candidates. The company is especially focused on therapies that can address unmet medical needs across a broad range of disease areas, including oncology, rare diseases, and infectious diseases. Through partnerships and subsidiary companies, Fortress Biotech advances its diversified portfolio, leveraging its expertise to strive for success across different therapeutic fields. The company's objectives revolve around transforming cutting-edge scientific research into groundbreaking treatments, aiming to improve patient outcomes and quality of life.